Related Experiment Video
Updated: May 17, 2026

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
Lack of relationship between microvascular and macrovascular disease in heart transplant recipients
Mohamed S Abu-Qaoud1, Liset N Stoletniy, David Chen
1Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Insights
Coronary vasculopathy in heart transplant recipients shows poor correlation between microvascular and macrovascular disease. Microvascular disease is linked to donor age and certain medications, suggesting different causes.
Area of Science:
- Cardiology
- Transplant Medicine
- Vascular Biology
Background:
- Coronary vasculopathy is a major factor in long-term survival after heart transplantation.
- Both macrovascular and microvascular disease impact prognosis, but their relationship and microvascular disease determinants are unclear in transplant patients.
Purpose of the Study:
- To investigate the relationship between coronary microvascular disease and macrovascular disease in heart transplant recipients.
- To identify determinants of coronary microvascular disease in this patient population.
Main Methods:
- Simultaneous endomyocardial biopsies and intravascular ultrasound (IVUS) images from 33 heart transplant recipients were analyzed.
- Coronary microvascular disease was graded by light microscopy; macrovascular disease was graded using IVUS and the Stanford classification.
- Microvascular and macrovascular disease grades were compared.
Main Results:
- Advanced microvascular disease (grades C and D) was present in 45% and 36% of patients, respectively.
- Macrovascular disease showed mostly lesser changes (grades 1-3), with no significant correlation to microvascular disease (P=0.10).
- Microvascular disease positively correlated with donor age (P=0.06), tacrolimus (P=0.02), and statin use (P=0.05).
Conclusions:
- A weak relationship exists between coronary microvascular and macrovascular disease in heart transplant recipients, suggesting distinct pathogenic pathways.
- Donor age is associated with increased microvascular disease.
- An unexpected positive association was observed between microvascular disease and treatment with tacrolimus and statins.
Background:
A key determinant of long-term survival in heart transplant recipients is the development of coronary vasculopathy. Both coronary macrovascular and microvascular disease are prognostically important. However, the relationship between these in transplant patients and the determinants of microvascular disease are not known.
Methods:
We reviewed the simultaneously obtained endomyocardial biopsies and intravascular ultrasound (IVUS) images of coronary arteries in 33 heart transplant recipients. Coronary microvascular disease was classified by light microscopy into four grades based on thickening of endothelial cell layer and stenotic versus nonstenotic medial wall thickening. Macrovascular disease was evaluated from IVUS studies and assigned into one of five grades based on the Stanford classification. Coronary microvascular and macrovascular diseases were compared.
Results:
Age at transplantation was 26 (18) years; 67% were men, and the average time to posttransplantation study was 4 years. Endomyocardial biopsy revealed more advanced grade C and D microvascular disease in 45% and 36% of the patients, respectively. However, IVUS analysis for macrovascular disease revealed mostly lesser changes with grade 1 in 12%, grade 2 in 61%, and grade 3 in 21%. There was no significant correlation between grades of microvascular and macrovascular disease (P=0.10). Microvascular disease correlated positively with donor age (P=0.06) and treatment with tacrolimus (0=0.02) and statins (P=0.05).
Conclusions:
There is a poor relationship between coronary microvascular and macrovascular disease in patients with cardiac transplants, likely indicating divergent pathogenetic mechanisms. Microvascular disease increases with donor age. There is an intriguing positive relationship between microvascular disease and treatment with statins and tacrolimus.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
